QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 神经外科重症患者失禁相关性皮炎的风险预警护理 期刊论文 护理学杂志, 2018, 期号: 11 作者:  汪慧娟;  郑红云;  蒋红 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 风险预警护理  失禁相关性皮炎  失禁  危重症患者   Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma 期刊论文 THERANOSTICS, 2018, 卷号: 8, 期号: 7 作者:  Zhao, Hongyun;  Wu, Meng;  Zhu, Leilei;  Tian, Yi;  Wu, Mingxing 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05 Hepatocellular carcinoma  cell-penetrating peptide  phase-transformation  low-intensity focus ultrasound  ultrasound molecular imaging  theranostics   Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects 期刊论文 2018, 卷号: 9, 页码: 1316 作者:  Zhou Ying;  Hu Pei;  Huang Yuguang;  Nuoer Sang;  Song Kaicheng 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 population pharmacodynamics  population pharmacokinetics  sedation  modeling  benzodiazepine   Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma 期刊论文 2018, 卷号: 9, 页码: 991 作者:  Yang, Fen;  Jiang, Min;  Lu, Ming;  Hu, Pei;  Wang, Hongyun 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 free vincristine  total vincristine  pharmacokinetics  vincristine sulfate liposome injection  urinary excretion  safety   Development and validation of a UPLC-MS/MS method for quantification of osimertinib (AZD9291) and its metabolite AZ5104 in human plasma 期刊论文 2018, 卷号: 32, 期号: 12, 页码: e4365 作者:   收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 AZ5104  EGFR-TKI  NSCLC  osimertinib  UPLC-MS/MS   Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC-MS/MS and its application to a PK study 期刊论文 2018, 卷号: 10, 期号: 11, 页码: 863-875 作者:   收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 first-in-human  Hemay005  human plasma  human urine  pharmacokinetics  psoriasis  UPLC-MS/MS   A validated UPLC-MS/MS method for the quantitation of an unstable peptide, monocyte locomotion inhibitory factor (MLIF) in human plasma and its application to a pharmacokinetic study 期刊论文 2018, 卷号: 157, 页码: 75-83 作者:   收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 MLIF  Ischemic stroke  UPLC-MS/MS  Pharmacokinetics  First-in-human   First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance 期刊论文 2018, 卷号: 13, 期号: 7, 页码: 968-977 作者:   收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 EGFR  T790M  cell-free DNA  next-generation sequencing   Simultaneous determination of morphine-6-d-glucuronide, morphine-3-d-glucuronide and morphine in human plasma and urine by ultra-performance liquid chromatography-tandem mass spectrometry: Application to M6G injection pharmacokinetic study 期刊论文 2018, 卷号: 32, 期号: 2 作者:  Xu, Wen;  Zhuang, Quankun;  Chen, Xia;  Jiang, Ji;  Hu, Pei 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 morphine  morphine-3-d-glucuronide  morphine-6-d-glucuronide  UPLC-MS  MS